For many pharmaceutical and biotech companies entering preclinical and clinical studies, their formulation is still in development. While most have prepared the formulation in their own lab, developing a formulation for sterile fill finish is a different challenge requiring different information. How do you scale up your formulation? Can your product be sterile filtered? How do you maintain homogeneity in suspensions? Is the drug product compatible with the vessel and tubing selected? How soon in advance does the drug product need to be prepared for filling activities? What equipment is needed in your formulation?

In this webinar, we describe how your CMO can help develop and scale-up your formulation. We will also discuss supporting studies and tests that can be performed to determine your equipment requirements and build your formulation process, and what information you will need to know before you contract with and fill finish CMO.

Ready to start your fill finish project? Reach out to us today!
[ Ссылка ]

00:00 - Intro
01:05 - Where the work starts & goals
03:36 - What your CDMO needs to know
05:12 - Development Rule of Thumb & Challenges
06:46 - Meeting Critical Properties
13:38 - Short-term & long-term stability
16:09 - Evaluating stability
19:11 - How to improve stability
22:27 - Scaling up
23:28 - Determining equipment requirements
25:35 - Achieving sterility
29:10 - Material compatibility
30:43 - Maintaining homogeneity in suspensions
34:06 - Sensitive formulations
37:13 - Viscous formulations
40:01 - Formulation development in summary
40:50 - Transition Q&A
41:50 - Q&A
48:15 - Conclusion

свернуть